Comparative proteomic analysis of metabolically labelled proteins from Plasmodium falciparum isolates with different adhesion properties
© Wu and Craig; licensee BioMed Central Ltd. 2006
Received: 18 April 2006
Accepted: 03 August 2006
Published: 03 August 2006
The virulence of Plasmodium falciparum relates in part to the cytoadhesion characteristics of parasitized erythrocytes but the molecular basis of the different qualitative and quantitative binding phenotypes is incompletely understood. This paucity of information is due partly to the difficulty in working with membrane proteins, the variant nature of these surface antigens and their relatively low abundance. To address this two-dimensional (2D) protein profiles of closely related, but phenotypically different laboratory strains of P. falciparum have been characterized using proteomic approaches. Since the mature erythrocyte has no nucleus and no protein synthesis capability, metabolic labelling of proteins was used to selectively identify parasite proteins and increase detection sensitivity.
A small number of changes (less than 10) were observed between four different P. falciparum laboratory strains with distinctive cytoadherence properties using metabolic labelling, with more parasite protein changes found in trophozoite iRBCs than ring stage. The combination of metabolic labelling and autoradiography can therefore be used to identify parasite protein differences, including quantitative ones, and in some cases to obtain protein identifications by mass spectrometry. The results support the suggestion that the membrane protein profile may be related to cytoadherent properties of the iRBCs. Most changes between parasite variants were differences in iso-electric point indicating differential protein modification rather than the presence or absence of a specific peptide.
The virulence of the human malaria parasite Plasmodium falciparum is believed to relate in part to adhesion of parasitized erythrocytes to postcapillary venular endothelium and other uninfected blood cells. At the molecular level, surface antigens from infected erythrocytes interact with several host receptors such as CD36 [1–3], Intercellular adhesion molecule-1 (ICAM-1) (CD54) , thrombospondin , E-selectin (CD62E), vascular cell adhesion molecule VCAM-1 (CD106) , P-selectin (CD62P) , αvβ3-integrin , platelet endothelial cell adhesion molecule-1 [PECAM-1 (CD31)] , Chondroitin sulfate A (CSA) , Complement receptor-1 (CR-1)),(CD35) , Heparan sulphate (HS)-like Glycosaminoglycan (GAG) , ABO blood group antigens  resulting in the rosetting, agglutination  and cytoadherence of iRBC. A parasite-derived adhesion molecule that mediates these interactions has been identified as P. falciparum erythrocyte membrane protein 1 (PfEMP1), which is encoded by the var multigene family [15–17]. There are about 60 var genes per parasite genome  that switch on expression in a mutually exclusive manner and contain copies of motifs that bind to diverse host receptors. Direct association of specific adhesive phenotype with disease has not been easy to demonstrate, except for pregnancy-associated malaria, in which the ability of iRBC to bind to placental receptors (such as CSA) is closely related to poor maternal and neonatal outcome . A number of other parasite proteins associated with the erythrocyte membrane and exported on the surface of parasitized erythrocytes have been reported, including, Rifin, Stevor, ring surface protein (RSP) 1/2, (for a review see ) and, more recently, Surfins . These proteins form part of a group of P. falciparum proteins that contain signals for export from the parasitophorous vacuole [22, 23]. Further bioinformatic analysis has proposed over 200 proteins that contain these signals and this behaviour appears to have been adopted much more extensively in P. falciparum than in other Plasmodium species , perhaps in part due to its requirement to undergo antigenic variation and cytoadherence.
There is a correlation between parasite clones of different antigenic type and cytoadherence [25, 26], rosette formation and pathogenesis, which has led to the studies on the diversity of these properties in P. falciparum isolates by testing binding to purified host proteins or cell lines. The parental P. falciparum line IT4/25/5 was originally selected by binding to ICAM-1, C32 amelanotic melanoma cells and Human umbilical vein endothelial cells (HUVEC), followed by sub-cloning to produce ItG , A4 and C24 . These parasite clones have distinctive cytoadherence properties [28, 29]. ItG is a high avidity ICAM-1 and CD36 binder, A4 has high avidity for CD36 and lower avidity to ICAM-1, and C24 binds strongly to CD36 with high avidity but not to ICAM-1. An unrelated parasite line, 3D7, is a low binding line, which has low avidity for CD36 and does not bind ICAM-1. However, the molecular basis underpinning these distinctive binding phenotypes and the molecules involved, other than PfEMP1, are poorly understood. Therefore, the very high resolving power of 2D autoradiography of metabolically-labelled proteins has been used to investigate these genotypically related clones that exhibit distinct adhesion phenotypes to identify the repertoire of molecules involved.
P. falciparum infection is a sophisticated system including adaptation and interaction of the human erythrocyte and the parasite. At the early ring stage, very few parasite proteins have been synthesized and so the contribution of the ring-stage parasite to the overall protein biomass of the infected erythrocyte is much less than the human proteins, making it hard to distinguish differences between parasite strain protein profiles at this stage. However, the mature human erythrocyte has no nucleus, no protein synthesis capability and no protein trafficking machinery. Metabolic labelling of proteins of P. falciparum can easily indicate parasite protein changes. Moreover, metabolic labelling is a more sensitive method for protein detection; the detection limit for silver stained protein spot is 200 ng while the limit for autoradiography of radioisotope labelled protein is 1 ng. In this study, metabolic incorporation was used to label cultured isolates of P. falciparum with [35S]methionine combined with biochemical enrichment of the infected erythrocyte membrane compartment. The objectives of this study were to use proteomic approaches to obtain a snapshot of P. falciparum infection at the protein level in the iRBC membrane and free parasite fractions, compare specific parasite strains to find molecules differentially expressed in parasite isolates with defined adhesion properties and to identify the proteins of interest using MALDI-TOF.
Materials and methods
The P. falciparum isolates used in this study were: ItG  A4, C24  and 3D7 [30, 31]. Parasites were cultured in vitro in group O+ human erythrocytes using previously described conditions . Briefly, parasites were cultured in RPMI1640 medium (supplemented with 37.5 mM HEPES, 7 mM D-glucose, 6 mM NaOH, 25 μg ml-1 gentamicin sulphate, 2 mM L-glutamine and 10% human serum) at a pH of 7.2 in a gas mixture of 96% nitrogen, 3% carbon dioxide and 1% oxygen. To minimize the effect of antigenic switching in culture, a batch of stabilates was prepared from post-selection cultures and used for no more than three weeks. To obtain specific life cycle stages of P. falciparum, 5% sorbitol treatment or Plasmagel flottation was used. For this study, the trophozoites were obtained 20–24 hours after invasion and ring stages were obtained 6–10 hours after invasion.
Synchronized parasite culture was incubated in 0.05% saponin for 10 minutes (min) in PBS on ice to lyse erythrocytes. The lysate was collected by centrifugation at 10000 × g for 5 min and washed three times with 10 mM Tris-HCl pH7.4 with 1× protease inhibitor Cocktail (Roche) until RBC ghosts were colourless. The lysate was divided into two fractions; red cell ghosts were collected from surface lysate and free parasite pellet from the bottom of the lysate. The two fractions were washed twice more with Tris-HCl buffer, pelleted and solubilized in 2D rehydration buffer [8 M urea, 2 M thiourea, 2% CHAPS, 65 mM dithiothreitol (DTT), and 0.5% ampholyte pH4-7 or 3–10]. For RBC ghost fraction, 50 μl chaotropic membrane extraction reagent 2 (Sigma) 5 M urea, 2 M thiourea, 40 mM Tris base, 2% CHAPS, 2% SB3-10 and 25 μl/ml of tributylphosphine (TBP) were added to help solubilize the erythrocyte membranes, and then solubilized in 2D rehydration buffer. Then the sample was vortexed, sonicated on ice 10 times for five seconds followed by centrifugation at 15000 × g for 10 min and the supernatant was subjected to 2D electrophoresis. The iso-electric focusing (IEF) was performed with pre-cast Amersham immobiline Drystrip gels using IPGphor IEF Unit (Amersham) initially for 10 h for 30 v, followed by 40 min at 200 v, 1 h at 500 v, 4 h at 2000 v and terminated with 8 h at 8000 v; a total of 80,000 vh. The focused strips were equilibrated in 10 ml equilibration solution (50 mM Tris-HCl, pH6.8, 6 M urea, 30% glycerol, 2% Sodium dodecyl sulphate (SDS)) with reducing agent of 1% DTT for 10 min, followed by 10 ml equilibration solution with 4.5% iodoacetamide for another 10 min. The strips were then washed twice briefly with 1 × SDS gel running buffer and loaded on 10% or 12.5% SDS-polyacrylamide gel electrophoresis (PAGE) gels for second dimension separation. The gels were usually run overnight using a Laemmli buffer system . Gels were stained either with Coomassie brilliant blue or silver nitrate according to a previously published protocol .
Metabolic labelling and fluorography
Parasites grown to specific developmental stages were adjusted to 10% parasitaemia and cells were washed with serum-free RPMI 1640 medium without methionine three times. In vitro metabolic labelling was carried out in methionine-free RPMI medium by the addition of 50 μCi/ml [35S] methionine for four hours under standard culture conditions. The reaction was stopped by removing the radioisotope by centrifugation and washing. To extract proteins from the radio-labelled culture, saponin was added to a final concentration of 0.15% at 4°C for 10 min to lyse the erythrocytes. Following centrifugation at 15,000 g at 4°C for 10 min., the iRBC ghost and free-parasite pellet were collected separately, washed three times using RPMI 1640 without serum and two times of 10 mM Tris-HCl pH7.4 until colourless. The samples were pelleted and subjected to 2D-electrophoresis. After electrophoresis, the gel was fixed and stained with Coomassie Blue, immersed in Amplify (Amersham) for 30 min and dried for fluorography. Following staining with Coomassie Blue or silver nitrate, 2D gel images were acquired using a Powerscan scanner and differential analysis was performed using 2D Evolution software (Nonlinear, Newcastle, UK).
Spot picking and in gel digestion
SDS-PAGE gels were Coomassie Brilliant Blue-stained and protein spots of interest either from the membrane enriched fractions (Figure 7) or free parasite fraction (Figure 8) were excised and put into Eppendorf Ultra Pure 1.5 ml centrifuge tube (to avoid contamination and false results from lower-grade plastics). The bands were then cut into 1 mm3 cubes and rinsed twice in 200 μl MilliQ water for 15 minutes. The gel slices were dehydrated by the addition of 100 μl of 50% (v/v) acetonitrile/water and incubated at room temperature for 10 minutes, and the dehydrants removed. 100 μl of ammonium bicarbonate (50 mM) was then added to each sample and incubated again at room temperature for 10 minutes. These last two steps were repeated. After removal of the ammonium bicarbonate the gel fragments were incubated in 10 μl of sequence grade trypsin (Promega) (10 μg/ml in 50 mM ammonium bicarbonate) for 18 hours at 37°C and then centrifuged. The supernatant was retained and the gel pellet treated with 20 μl of 70% acetonitrile (v/v in water) for 10 minutes at room temperature. The supernatant from this step was then removed and pooled with the previous supernatant. The combined supernatant was dried in a rotational vacuum concentrator (RVC2-18), resuspended in 15 μl water, dried again and resuspended in 12 μl of 10% acetonitrile and 0.1% formic acid (in water).
MALDI-TOF mass spectrometry
Samples were loaded in a sandwich manner by adding and immediately removing 0.5 μl matrix [10 mg cyano-4-hydroxycin-namic acid (Sigma) in 1 ml 50% acetonitrile and 0.05% trifluoroacetic acid (TFA)] onto a stainless steel target. Then 0.5 μl of prepared sample was spotted directly onto the target and an equal volume of matrix was added. High-resolution spectra were obtained using a Axima-CFR plus MALDI ToF instrument (Kratos Analytical, Manchester, UK) in reflectron mode. External calibration was performed using a mixed 3 point standards (Angiotensin II, 1046.54, ACTH fragment 18–39, 2465.19, Bradykinin gragment 1–7, 757.39, Sigma) adjacent to the samples. Acquisition and data processing are controlled by Launchpad software (Kratos Analytical, Manchester, UK).
Protein identification was performed by sending trypsin digested peptide masses to three databases (NCBI, MSDA and Swissprot) separately using the MASCOT Peptide Mass Fingerprinting program . All the modifications listed in the searching programme were considered individually as a parameter for the search. The monoisotopic masses were used and the mass tolerance was set to 0.5Da.
Results and discussion
Protein identifications (see Fig. 7)
No. of peptides matched
% of SQ rec
Glycophorin-binding protein 130 precursor
78KD glucose regulated protein
78KD glucose regulated protein
Protein disulfide isomerase
Endoplasmic reticulum-resident calcium binding protein
Variant surface antigen rifin
Peptidyl-prolyl cis-trans isomerase
Parasite proteins only account for a small amount of total infected erythrocyte proteins, with over 70% of the protein spots identified as human proteins (data not shown). To further extract parasite proteins for identification, parasites were synchronized by Plasmagel flottation to enrich trophozoite stage parasites up to 80%, treated infected erythrocytes with saponin for less than 7 min and then washed the free-parasite fraction extensively. The brief saponin treatment produces large pieces of erythrocyte membrane and free parasite, repeated washing with ice cold saline solution removes most of the contaminating host erythrocyte lysate and, therefore, enriches for parasite proteins. This sample was separated by 2D gel electrophoresis (Figure 8) and using MALDI-TOF, 58 proteins were identified from this gel, of which 28 came from parasite source.
A number of techniques can be used to increase the rate of protein identification and try to find the surface protein specifically. For example, Multidimensional Protein Identification Technology (MudPIT), a two-dimensional liquid chromatograph coupled with tandem mass spectrometry ; molecules exposed on the iRBC surface can be digested by enzyme treatment such as trypsin or chymotrypsin [40, 41]; insertion molecules can be purified from membrane fractions . Yimin Wu's group used biotin-streptavidin labeling to purify all proteins on the iRBC surface and identified proteins by shotgun proteomic analysis . Such techniques certainly provide high throughput scale and improve the identification sensitivity. However, a problem still remained as some cytosol proteins were also present in the pool of surface proteins because of internal biotin labelling and high abundant protein non-specifically binding to streptavidin. Recently, Lingelbach's group has used furosemide, a non-specific anion transport inhibitor, to block parasite-induced biotin permeability, making biotin-streptavidin technique more specific . Another way to trace protein trafficking or protein remodelling or protein targeting is by in silico prediction of host-targeting signals required for the export of proteins from the parasite vacuole to the erythrocyte membrane [22, 23].
The predominant modification seen on 2D gels was horizontal position changes rather than presence or absence of a protein, indicating protein post-translational modification such as phosphorylation, which increases the negative charge of the protein and shifts the iso-electric point (PI) to the more acidic side. In yeast, protein phosphorylation is estimated to affect 30% of the proteome. Using proteome chip technology, scientists have determined the in vitro substrates recognized by yeast protein kinases. 4,192 phosphorylation events involving 1,325 different proteins were identified and kinase-substrate relationships distinguished . The results suggest that host and parasite proteins may experience phosphorylation changes during parasite development inside the erythrocytes.
Using a sensitive in vivo labelling technique allied to 2D electrophoresis, highly reproducible, limited changes in P. falciparum protein profiles from a number of parasite lines have been shown, differing in their adhesive phenotypes, with even fewer differences seen in antigenically distinct clones sharing the ability to bind to ICAM-1. Of the changes detected, most were alterations in PI, indicative of differential phosphorylation. Only a subset of the protein spots could be identified using mass spectrometry. Other studies have used non-gel methodologies, such as nano-LC/MS/MS to overcome this problem, but these also have limitations for low abundance, membrane proteins and several proteins known to be at the surface of the infected erythrocyte were not identified by this approach. Further development of biochemical techniques, detection systems and sequence databases, particularly for variant surface antigen families, will be required to identify the full complement of parasite proteins in the infected erythrocyte membrane.
We would like to thank Prof. John Hyde and Drs. Paul Sims and Niroshini Nirmalan (University of Manchester) for their help in establishing 2D electrophoresis in our laboratory, Ms. Evelyn Gitau for her help with mass spectrometry and Prof. Steve Ward and Dr Rob Harrison for discussions and critical reading of the manuscript. This work was funded by the Wellcome Trust (Functional Genomics Initiative).
- Barnwell JW, Asch AS, Nachman RL, Yamaya M, Aikawa M, Ingravallo P: A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes. J Clin Invest. 1989, 84 (3): 765-772.PubMed CentralView ArticlePubMedGoogle Scholar
- Oquendo P, Hundt E, Lawler J, Seed B: CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes. Cell. 1989, 58 (1): 95-101. 10.1016/0092-8674(89)90406-6.View ArticlePubMedGoogle Scholar
- Ockenhouse CF, Tandon NN, Magowan C, Jamieson GA, Chulay JD: Identification of a platelet membrane glycoprotein as a falciparum malaria sequestration receptor [see comments]. Science. 1989, 243 (4897): 1469-1471.View ArticlePubMedGoogle Scholar
- Berendt AR, Simmons DL, Tansey J, Newbold CI, Marsh K: Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum. Nature. 1989, 341 (6237): 57-59. 10.1038/341057a0.View ArticlePubMedGoogle Scholar
- Roberts DD, Sherwood JA, Spitalnik SL, Panton LJ, Howard RJ, Dixit VM, Frazier WA, Miller LH, Ginsburg V: Thrombospondin binds falciparum malaria parasitized erythrocytes and may mediate cytoadherence. Nature. 1985, 318 (6041): 64-66. 10.1038/318064a0.View ArticlePubMedGoogle Scholar
- Ockenhouse CF, Tegoshi T, Maeno Y, Benjamin C, Ho M, Kan KE, Thway Y, Win K, Aikawa M, Lobb RR: Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1. J Exp Med. 1992, 176 (4): 1183-1189. 10.1084/jem.176.4.1183.View ArticlePubMedGoogle Scholar
- Udomsangpetch R, Reinhardt PH, Schollaardt T, Elliott JF, Kubes P, Ho M: Promiscuity of clinical Plasmodium falciparum isolates for multiple adhesion molecules under flow conditions. J Immunol. 1997, 158 (9): 4358-4364.PubMedGoogle Scholar
- Siano JP, Grady KK, Millet P, Wick TM: Short report: Plasmodium falciparum: cytoadherence to alpha(v)beta3 on human microvascular endothelial cells. Am J Trop Med Hyg. 1998, 59 (1): 77-79.PubMedGoogle Scholar
- Treutiger CJ, Heddini A, Fernandez V, Muller WA, Wahlgren M: PECAM-1/CD31, an endothelial receptor for binding Plasmodium falciparum- infected erythrocytes [see comments]. Nat Med. 1997, 3 (12): 1405-1408. 10.1038/nm1297-1405.View ArticlePubMedGoogle Scholar
- Rogerson SJ, Chaiyaroj SC, Ng K, Reeder JC, Brown GV: Chondroitin sulfate A is a cell surface receptor for Plasmodium falciparum-infected erythrocytes. J Exp Med. 1995, 182 (1): 15-20. 10.1084/jem.182.1.15.View ArticlePubMedGoogle Scholar
- Rowe JA, Moulds JM, Newbold CI, Miller LH: P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature. 1997, 388 (6639): 292-295. 10.1038/40888.View ArticlePubMedGoogle Scholar
- Vogt AM, Winter G, Wahlgren M, Spillmann D: Heparan sulphate identified on human erythrocytes: a Plasmodium falciparum receptor. Biochem J. 2004, 381 (Pt 3): 593-597.PubMed CentralView ArticlePubMedGoogle Scholar
- Chen Q, Heddini A, Barragan A, Fernandez V, Pearce SF, Wahlgren M: The semiconserved head structure of Plasmodium falciparum erythrocyte membrane protein 1 mediates binding to multiple independent host receptors. J Exp Med. 2000, 192 (1): 1-10. 10.1084/jem.192.1.1.PubMed CentralView ArticlePubMedGoogle Scholar
- Roberts DJ, Pain A, Kai O, Kortok M, Marsh K: Autoagglutination of malaria-infected red blood cells and malaria severity [letter]. Lancet. 2000, 355 (9213): 1427-1428. 10.1016/S0140-6736(00)02143-7.View ArticlePubMedGoogle Scholar
- Baruch DI, Pasloske BL, Singh HB, Bi X, Ma XC, Feldman M, Taraschi TF, Howard RJ: Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes [see comments]. Cell. 1995, 82 (1): 77-87. 10.1016/0092-8674(95)90054-3.View ArticlePubMedGoogle Scholar
- Su XZ, Heatwole VM, Wertheimer SP, Guinet F, Herrfeldt JA, Peterson DS, Ravetch JA, Wellems TE: The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes [see comments]. Cell. 1995, 82 (1): 89-100. 10.1016/0092-8674(95)90055-1.View ArticlePubMedGoogle Scholar
- Smith JD, Chitnis CE, Craig AG, Roberts DJ, Hudson-Taylor DE, Peterson DS, Pinches R, Newbold CI, Miller LH: Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes [see comments]. Cell. 1995, 82 (1): 101-110. 10.1016/0092-8674(95)90056-X.PubMed CentralView ArticlePubMedGoogle Scholar
- Gardner MJ, Hall N, Fung E, White O, Berriman M, Hyman RW, Carlton JM, Pain A, Nelson KE, Bowman S, Paulsen IT, James K, Eisen JA, Rutherford K, Salzberg SL, Craig A, Kyes S, Chan MS, Nene V, Shallom SJ, Suh B, Peterson J, Angiuoli S, Pertea M, Allen J, Selengut J, Haft D, Mather MW, Vaidya AB, Martin DM, Fairlamb AH, Fraunholz MJ, Roos DS, Ralph SA, McFadden GI, Cummings LM, Subramanian GM, Mungall C, Venter JC, Carucci DJ, Hoffman SL, Newbold C, Davis RW, Fraser CM, Barrell B: Genome sequence of the human malaria parasite Plasmodium falciparum. Nature. 2002, 419 (6906): 498-511. 10.1038/nature01097.View ArticlePubMedGoogle Scholar
- Fried M, Duffy PE: Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta [see comments]. Science. 1996, 272 (5267): 1502-1504.View ArticlePubMedGoogle Scholar
- Craig A, Scherf A: Molecules on the surface of the Plasmodium falciparum infected erythrocyte and their role in malaria pathogenesis and immune evasion. Mol Biochem Parasitol. 2001, 115 (2): 129-143. 10.1016/S0166-6851(01)00275-4.View ArticlePubMedGoogle Scholar
- Winter G, Kawai S, Haeggstrom M, Kaneko O, von Euler A, Kawazu S, Palm D, Fernandez V, Wahlgren M: SURFIN is a polymorphic antigen expressed on Plasmodium falciparum merozoites and infected erythrocytes. J Exp Med. 2005, 201 (11): 1853-1863. 10.1084/jem.20041392.PubMed CentralView ArticlePubMedGoogle Scholar
- Hiller NL, Bhattacharjee S, van Ooij C, Liolios K, Harrison T, Lopez-Estrano C, Haldar K: A host-targeting signal in virulence proteins reveals a secretome in malarial infection. Science. 2004, 306 (5703): 1934-1937. 10.1126/science.1102737.View ArticlePubMedGoogle Scholar
- Marti M, Good RT, Rug M, Knuepfer E, Cowman AF: Targeting malaria virulence and remodeling proteins to the host erythrocyte. Science. 2004, 306 (5703): 1930-1933. 10.1126/science.1102452.View ArticlePubMedGoogle Scholar
- Sargeant TJ, Marti M, Caler E, Carlton JM, Simpson K, Speed TP, Cowman AF: Lineage-specific expansion of proteins exported to erythrocytes in malaria parasites. Genome Biol. 2006, 7 (2): R12-10.1186/gb-2006-7-2-r12.PubMed CentralView ArticlePubMedGoogle Scholar
- Roberts DJ, Craig AG, Berendt AR, Pinches R, Nash G, Marsh K, Newbold CI: Rapid switching to multiple antigenic and adhesive phenotypes in malaria [see comments]. Nature. 1992, 357 (6380): 689-692. 10.1038/357689a0.PubMed CentralView ArticlePubMedGoogle Scholar
- Biggs BA, Anders RF, Dillon HE, Davern KM, Martin M, Petersen C, Brown GV: Adherence of infected erythrocytes to venular endothelium selects for antigenic variants of Plasmodium falciparum. J Immunol. 1992, 149 (6): 2047-2054.PubMedGoogle Scholar
- Ockenhouse CF, Ho M, Tandon NN, Van Seventer GA, Shaw S, White NJ, Jamieson GA, Chulay JD, Webster HK: Molecular basis of sequestration in severe and uncomplicated Plasmodium falciparum malaria: differential adhesion of infected erythrocytes to CD36 and ICAM-1. J Infect Dis. 1991, 164 (1): 163-169.View ArticlePubMedGoogle Scholar
- Gray C, McCormick C, Turner G, Craig A: ICAM-1 can play a major role in mediating P. falciparum adhesion to endothelium under flow. Mol Biochem Parasitol. 2003, 128 (2): 187-193. 10.1016/S0166-6851(03)00075-6.View ArticlePubMedGoogle Scholar
- Tse MT, Chakrabarti K, Gray C, Chitnis CE, Craig A: Divergent binding sites on intercellular adhesion molecule-1 (ICAM-1) for variant Plasmodium falciparum isolates. Mol Microbiol. 2004, 51 (4): 1039-1049. 10.1046/j.1365-2958.2003.03895.x.View ArticlePubMedGoogle Scholar
- Delemarre BJ, van der Kaay HJ: [Tropical malaria contracted the natural way in the Netherlands]. Ned Tijdschr Geneeskd. 1979, 123 (46): 1981-1982.PubMedGoogle Scholar
- Walliker D, Quakyi IA, Wellems TE, McCutchan TF, Szarfman A, London WT, Corcoran LM, Burkot TR, Carter R: Genetic analysis of the human malaria parasite Plasmodium falciparum. Science. 1987, 236 (4809): 1661-1666.View ArticlePubMedGoogle Scholar
- Trager W, Jensen JB: Human malaria parasites in continuous culture. Science. 1976, 193 (4254): 673-675.View ArticlePubMedGoogle Scholar
- Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970, 227 (5259): 680-685. 10.1038/227680a0.View ArticlePubMedGoogle Scholar
- Nirmalan N, Sims PF, Hyde JE: Quantitative proteomics of the human malaria parasite Plasmodium falciparum and its application to studies of development and inhibition. Mol Microbiol. 2004, 52 (4): 1187-1199. 10.1111/j.1365-2958.2004.04049.x.View ArticlePubMedGoogle Scholar
- MASCOT Peptide Mass Fingerprinting program MS: http://www.matrixscience.com.Google Scholar
- Magowan C, Nunomura W, Waller KL, Yeung J, Liang J, Van Dort H, Low PS, Coppel RL, Mohandas N: Plasmodium falciparum histidine-rich protein 1 associates with the band 3 binding domain of ankyrin in the infected red cell membrane. Biochim Biophys Acta. 2000, 1502 (3): 461-470.View ArticlePubMedGoogle Scholar
- Pei X, An X, Guo X, Tarnawski M, Coppel R, Mohandas N: Structural and functional studies of interaction between Plasmodium falciparum knob-associated histidine-rich protein (KAHRP) and erythrocyte spectrin. J Biol Chem. 2005, 280 (35): 31166-31171. 10.1074/jbc.M505298200.View ArticlePubMedGoogle Scholar
- Paulitschke M, Nash GB: Membrane rigidity of red blood cells parasitized by different strains of Plasmodium falciparum. J Lab Clin Med. 1993, 122 (5): 581-589.PubMedGoogle Scholar
- Washburn MP, Yates JR: Analysis of the microbial proteome. Curr Opin Microbiol. 2000, 3 (3): 292-297. 10.1016/S1369-5274(00)00092-8.View ArticlePubMedGoogle Scholar
- Puentes A, Ocampo M, Rodriguez LE, Vera R, Valbuena J, Curtidor H, Garcia J, Lopez R, Tovar D, Cortes J, Rivera Z, Patarroyo ME: Identifying Plasmodium falciparum merozoite surface protein-10 human erythrocyte specific binding regions. Biochimie. 2005, 87 (5): 461-472. 10.1016/j.biochi.2005.01.001.View ArticlePubMedGoogle Scholar
- Curtidor H, Urquiza M, Suarez JE, Rodriguez LE, Ocampo M, Puentes A, Garcia JE, Vera R, Lopez R, Ramirez LE, Pinzon M, Patarroyo ME: Plasmodium falciparum acid basic repeat antigen (ABRA) peptides: erythrocyte binding and biological activity. Vaccine. 2001, 19 (31): 4496-4504. 10.1016/S0264-410X(01)00202-X.View ArticlePubMedGoogle Scholar
- Low TY, Seow TK, Chung MC: Separation of human erythrocyte membrane associated proteins with one-dimensional and two-dimensional gel electrophoresis followed by identification with matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Proteomics. 2002, 2 (9): 1229-1239. 10.1002/1615-9861(200209)2:9<1229::AID-PROT1229>3.0.CO;2-N.View ArticlePubMedGoogle Scholar
- Florens L, Liu X, Wang Y, Yang S, Schwartz O, Peglar M, Carucci DJ, Yates JR, Wu Y: Proteomics approach reveals novel proteins on the surface of malaria-infected erythrocytes. Mol Biochem Parasitol. 2004, 135 (1): 1-11. 10.1016/j.molbiopara.2003.12.007.View ArticlePubMedGoogle Scholar
- Baumeister S, Endermann T, Charpian S, Nyalwidhe J, Duranton C, Huber S, Kirk K, Lang F, Lingelbach K: A biotin derivative blocks parasite induced novel permeation pathways in Plasmodium falciparum-infected erythrocytes. Mol Biochem Parasitol. 2003, 132 (1): 35-45. 10.1016/j.molbiopara.2003.08.003.View ArticlePubMedGoogle Scholar
- Ptacek J, Devgan G, Michaud G, Zhu H, Zhu X, Fasolo J, Guo H, Jona G, Breitkreutz A, Sopko R, McCartney RR, Schmidt MC, Rachidi N, Lee SJ, Mah AS, Meng L, Stark MJ, Stern DF, De Virgilio C, Tyers M, Andrews B, Gerstein M, Schweitzer B, Predki PF, Snyder M: Global analysis of protein phosphorylation in yeast. Nature. 2005, 438 (7068): 679-684. 10.1038/nature04187.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.